Headquarters
2 RIDGEVIEW DR, LITTLE ROCK, AR 72227, US
LITTLE ROCK, AR, US
From the company
CytoAstra is developing the Cytophone platform, which uses In Vivo Photoacoustic Flow Cytometry (PAFC) for early diagnosis of life-threatening diseases including cancers, infections, and cardiovascular disorders, with a focus on melanoma, malaria, and strokes. The technology is noninvasive, label-free, and operates through intact skin using a laser and ultrasound transducers. CytoAstra is also developing a therapeutic device that can detect and treat cancer and infected cells using photoacoustic and photothermal technologies.
2 RIDGEVIEW DR, LITTLE ROCK, AR 72227, US
Quantities, certifications, and timing.